USPTO serial 97302599
Reviewed by CopyMark Law Group
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sara M. Bauer
Sara M. Bauer Womble Bond Dickinson (US) LLP470 Atlantic Avenue, Suite 600Independence WharfBoston, MA 02110| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Hydrogel for medical purposes; Natural biomaterial for delivery of immunotherapy; pharmaceutical preparations used to modulate an immune response; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting immune-suppressive cells; pharmaceutical preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, biomaterials to extend the release of immunotherapy treatments at the site of tumor resection; Natural intraoperative biomaterial for delivery of immunotherapy | ACTIVE | Feb 4, 2026 |
| 010 | Artificial biomaterial for delivery of immunotherapy; Artificial intraoperative biomaterial for delivery of immunotherapy | ACTIVE | Feb 4, 2026 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 8, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 7, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 7, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 7, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 21, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Apr 21, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 1, 2026 | IUAF | USE AMENDMENT FILED | — |
| Mar 1, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 16, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 15, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 15, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 15, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 16, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 16, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 16, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 16, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 8, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 8, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 8, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 8, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 23, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 4, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 27, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 7, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 7, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 24, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 24, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 24, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 24, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 24, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 7, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 27, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 27, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 27, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 27, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 27, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 25, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Aug 25, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jun 8, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 4, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 4, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 4, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 4, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 4, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 4, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 21, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 21, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 21, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 21, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 24, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 14, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 12, 2022 | NWAP | NEW APPLICATION ENTERED | — |